FAKTOR OPTIONSSCHEIN - BRISTOL-MYERS SQUIBB | Real-time BOERSE MUENCHEN 12:26:14 2024-06-10 pm EDT | ||
| 11.32 EUR | -2.70% |
|
| Current month | -0.55% | ||
| 1 month | +11.88% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BRISTOL-MYERS SQUIBB COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 24-06-10 | 11.32 | -2.70% |
| 24-06-07 | 11.64 | -0.43% |
| 24-06-06 | 11.69 | +0.70% |
| 24-06-05 | 11.61 | +3.49% |
| 24-06-04 | 11.22 | +0.95% |
Real-time BOERSE MUENCHEN
Last update June 10, 2024 at 12:26 pm EDT
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | BRISTOL-MYERS SQUIBB COMPANY |
| Issuer | Goldman Sachs |
| WKN | GG402F |
| ISIN | DE000GG402F4 |
| Date issued | 2024-02-20 |
| Strike | 62.22 $ |
| Maturity | Unlimited |
| Parity | 1.67 : 1 |
| Emission price | 8.62 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 12.35 € |
|---|---|
| Lowest since issue | 7.005 € |
| Spread | 0.01 € |
| Spread % | 0.09% |
Company Profile
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.
The United States account for 70.1% of net sales.
Sector
-
Ratings for Bristol-Myers Squibb Company
Trading Rating
Investor Rating
ESG Refinitiv
B
Consensus: Bristol-Myers Squibb Company
Sell
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
41.48
USD
Average target price
53.19
USD
Spread / Average Target
+28.24%
- Stock Market
- Certificates
- Certificat
